isradipine has been researched along with Cardiomyopathy, Dilated in 3 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
Cardiomyopathy, Dilated: A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.
Excerpt | Relevance | Reference |
---|---|---|
" In the present study, we investigated the potential beneficial effect of chronic treatment with a dual L-type Ca2+ and slow Na+ channel blockers isradipine, on the development of necrosis in myopathic hamster hearts." | 7.72 | Isradipine prevents the development of spontaneously occurring cardiac necrosis in cardiomyopathic hamster. ( Bkaily, G; Chahine, M; D'Orléans-Juste, P; Jacques, D; Jasmin, G, 2003) |
" In the present study, we investigated the potential beneficial effect of chronic treatment with a dual L-type Ca2+ and slow Na+ channel blockers isradipine, on the development of necrosis in myopathic hamster hearts." | 3.72 | Isradipine prevents the development of spontaneously occurring cardiac necrosis in cardiomyopathic hamster. ( Bkaily, G; Chahine, M; D'Orléans-Juste, P; Jacques, D; Jasmin, G, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jacques, D | 1 |
Bkaily, G | 1 |
Jasmin, G | 1 |
D'Orléans-Juste, P | 1 |
Chahine, M | 1 |
Gruver, EJ | 1 |
Glass, MG | 1 |
Marsh, JD | 1 |
Gwathmey, JK | 1 |
Rasmussen, RP | 1 |
Minobe, W | 1 |
Bristow, MR | 1 |
3 other studies available for isradipine and Cardiomyopathy, Dilated
Article | Year |
---|---|
Isradipine prevents the development of spontaneously occurring cardiac necrosis in cardiomyopathic hamster.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Cardiomyopathy, Dilated; Cricetinae; Is | 2003 |
An animal model of dilated cardiomyopathy: characterization of dihydropyridine receptors and contractile performance.
Topics: Analysis of Variance; Animals; Calcium Channels; Calcium Channels, L-Type; Cardiomyopathy, Dilated; | 1993 |
Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium.
Topics: Calcium Channel Blockers; Calcium Channels; Cardiomyopathy, Dilated; Cell Membrane; Humans; Iodocyan | 1990 |